KYMERA THERAPEUTICS INC (KYMR) Stock Cash Flow
NASDAQ:KYMR - Nasdaq - US5015751044 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -240.88M | -223.86M | -146.96M | -154.81M | -100.22M | |||
| Depreciation Amortization | 7.96M | 7.37M | 3.56M | 2.98M | 2.40M | |||
| Change In Working Capital | -44.98M | -23.97M | 2.68M | -37.62M | -61.92M | |||
| Interest Paid | 234.00K | 206.00K | 162.00K | 180.00K | 160.00K | |||
| Other non cash items | 43.84M | 45.95M | 37.89M | 36.37M | 30.80M | |||
| OPERATING CASH FLOW | -234.06M | -194.50M | -102.83M | -153.09M | -128.95M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.90M | -12.84M | -34.48M | -2.84M | -1.60M | |||
| Other Investing Activity | -18.95M | -391.24M | 174.37M | 23.36M | -98.24M | |||
| INVESTING CASH FLOW | -24.86M | -404.08M | 139.89M | 20.52M | -99.84M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.56M | -1.58M | -76.00K | -1.13M | -850.00K | |||
| Stock Issued/Repurchased | 256.92M | 610.43M | 4.27M | 154.13M | 249.18M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 0.00 | 1.95M | |||
| FINANCING CASH FLOW | 255.35M | 608.85M | 4.19M | 153.00M | 250.28M | |||
| CHANGE IN CASH | -3.56M | 10.27M | 41.25M | 20.43M | 21.49M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -234.06M | -194.50M | -102.83M | -153.09M | -128.95M | |||
| Capital Expenditure | -5.90M | -12.84M | -34.48M | -2.84M | -1.60M | |||
| FREE CASH FLOW | -239.96M | -207.34M | -137.31M | -155.93M | -130.55M | |||
All data in USD